Ariad gets early FDA approval for leukemia drug

(Reuters) - The U.S. Food and Drug Administration on Friday granted earlier-than-expected approval to Ariad Pharmaceuticals Inc's drug for two rares types of leukemia, but is requiring that patients be warned of potential side effects, sending the company's shares down nearly 20 percent.

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/wcKhvbcGcZI/us-ariadpharmaceuticals-approval-cancerd-idUSBRE8BD0XY20121214

phlebotomy certification maryland phlebotomy certification in maryland cheap phlebotomy training in california